Because MeiYanoL reduces inflmmation
and therefore VCAM-1 expression, fewer
leukocytes will be bound to endothelial
cells. As a result, fewer monocytes will
cross the blood vessel walls (2) hence
reducing both plasma accumulation
(edema) and red blood cell leak (dark
circles) .
This process ensures that MeiYanoL
effectively prevents and reduces eye bags
and dark circles. The anti-dark circle effect
is further enhanced because of the chelating
power that will reduce iron oxidation
which is involved in coloration.